Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Trial · NCT01950819
Results by group156
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 156
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Incidence of Failure on the Composite of Treated Biopsy-proven Acute Rejection (tBPAR) or Estimated Glomerular Filtration Rate (eGFR) < 50 mL/Min/1.73m2. | EVR+rCNI | month 12 | 489 | Participants | |
| Incidence of Failure on the Composite of Treated Biopsy-proven Acute Rejection (tBPAR) or Estimated Glomerular Filtration Rate (eGFR) < 50 mL/Min/1.73m2. | MPA+sCNI | month 12 | 456 | Participants | |
| Incidence of Failure on the Composite of Treated Biopsy-proven Acute Rejection (tBPAR) or Estimated Glomerular Filtration Rate (eGFR) < 50 mL/Min/1.73m2. | EVR+rCNI | month 24 | 489 | Participants | |
| Incidence of Failure on the Composite of Treated Biopsy-proven Acute Rejection (tBPAR) or Estimated Glomerular Filtration Rate (eGFR) < 50 mL/Min/1.73m2. | MPA+sCNI | month 24 | 443 | Participants | |
| Incidence of Failure on the Composite of (Treated Biopsy Proven Acute Rejection (tBPAR), Graft Loss or Death | EVR+rCNI | month 12 | 146 | Participants | |
| Incidence of Failure on the Composite of (Treated Biopsy Proven Acute Rejection (tBPAR), Graft Loss or Death | MPA+sCNI | month 12 | 131 | Participants | |
| Incidence of Failure on the Composite of (Treated Biopsy Proven Acute Rejection (tBPAR), Graft Loss or Death | EVR+rCNI | month 24 | 169 | Participants | |
| Incidence of Failure on the Composite of (Treated Biopsy Proven Acute Rejection (tBPAR), Graft Loss or Death | MPA+sCNI | month 24 | 147 | Participants | |
| Incidence of Failure on the Composite Endpoint of tBPAR, Graft Loss, Death or eGFR < 50 mL/Min/1.73m2 | EVR+rCNI | month 12 | 497 | Participants | |
| Incidence of Failure on the Composite Endpoint of tBPAR, Graft Loss, Death or eGFR < 50 mL/Min/1.73m2 | MPA+sCNI | month 12 | 466 | Participants | |
| Incidence of Failure on the Composite Endpoint of tBPAR, Graft Loss, Death or eGFR < 50 mL/Min/1.73m2 | EVR+rCNI | month 24 | 497 | Participants | |
| Incidence of Failure on the Composite Endpoint of tBPAR, Graft Loss, Death or eGFR < 50 mL/Min/1.73m2 | MPA+sCNI | month 24 | 457 | Participants | |
| Incidence of Failure on the Composite Endpoint of Graft Loss or Death. | EVR+rCNI | month 12 | 51 | Participants | |
| Incidence of Failure on the Composite Endpoint of Graft Loss or Death. | MPA+sCNI | month 12 | 54 | Participants | |
| Incidence of Failure on the Composite Endpoint of Graft Loss or Death. | EVR+rCNI | month 24 | 67 | Participants | |
| Incidence of Failure on the Composite Endpoint of Graft Loss or Death. | MPA+sCNI | month 24 | 65 | Participants | |
| Incidence of Death, Graft Loss, tBPAR, BPAR, tAR, AR and Humoral Rejection | EVR+rCNI | deaths month 12 | 20 | Participants | |
| Incidence of Death, Graft Loss, tBPAR, BPAR, tAR, AR and Humoral Rejection | MPA+sCNI | deaths month 12 | 28 | Participants | |
| Incidence of Death, Graft Loss, tBPAR, BPAR, tAR, AR and Humoral Rejection | EVR+rCNI | deaths month 24 | 32 | Participants | |
| Incidence of Death, Graft Loss, tBPAR, BPAR, tAR, AR and Humoral Rejection | MPA+sCNI | deaths month 24 | 36 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01950819/results